[Federal Register Volume 67, Number 95 (Thursday, May 16, 2002)]
[Notices]
[Page 34937]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-12236]



[[Page 34937]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


National Vaccine Advisory Committee, Subcommittee on Future 
Vaccines, Subcommittee on Immunization Coverage, and Subcommittee on 
Vaccine Safety and Communication Meetings

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following Federal advisory committee 
meetings.

    Name: National Vaccine Advisory Committee (NVAC).
    Times and Dates: 9 a.m.-2 p.m., June 4, 2002. 8:30 a.m.-3 p.m., 
June 5, 2002.
    Place: Hubert H. Humphrey Building, Room 505A, 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Notice: In the interest of security, the Department has 
instituted stringent procedures for entrance to the Hubert H. 
Humphrey Building by non-government employees. Thus, persons without 
a government identification card should plan to arrive at the 
building each day either between 8 a.m. and 8:30 a.m. or 12:30 p.m. 
and 1 p.m. Entrance to the meeting at other times during the day 
cannot be assured.
    Purpose: This committee advises and makes recommendations to the 
Director of the National Vaccine Program on matters related to the 
Program responsibilities.
    Matters to be Discussed: Agenda items will include: a report 
from the National Vaccine Program Office (NVPO) and the Interagency 
Vaccine Workgroup; a report from the Assistant Secretary for Health; 
discussions on compensation for vaccine administration by the Center 
for Medicare and Medical Services, the American Academy of 
Pediatrics, and American College of Physicians; a discussion of 
current issues involving the supply of vaccines and a report on the 
Vaccine Supply Workshop; a discussion on the global supply of 
pandemic influenza vaccine; a discussion on the future of rotavirus 
vaccine; reports from the NVAC Subcommittees; a presentation on 
increasing public participation in dialogue and deliberation about 
vaccines; a discussion of issues and NVAC role regarding travelers' 
vaccines; a report on the Workshop on Implementing Immunization 
Recommendations; reports from the Advisory Committee on Immunization 
Practices/NVAC Smallpox Working Group, the Advisory Commission on 
Childhood Vaccines/Division of Vaccine Injury Compensation, the 
Vaccine and Related Biological Products Advisory Committee/Food and 
Drug Administration, and the Advisory Committee on Immunization 
Practices/National Immunization Program, Centers for Disease Control 
and Prevention.

    Name: Subcommittee on Future Vaccines.
    Time and Date: 2 p.m.-5 p.m., June 4, 2002.
    Place: Hubert H. Humphrey Building, Room 305A, 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: This subcommittee develops policy options and guides 
national activities that lead to accelerated development, licensure, 
and the best use of new vaccines in the simplest possible 
immunization schedules.
    Matters to be Discussed: Agenda items will include Pneumococcal 
Disease Prevention in Adults-Workshop planning; and, discussion 
topics for future Subcommittee meetings.

    Name: Subcommittee on Immunization Coverage.
    Time and Date: 2 p.m.-5 p.m., June 4, 2002.
    Place: Hubert H. Humphrey Building, Room 505A, 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: This subcommittee will identify and propose solutions 
that provide a multifaceted and holistic approach to reducing 
barriers that result in low immunization coverage for children.
    Matters to be Discussed: Agenda items will include an update on 
the publication of the newly revised Adult and Pediatric Standards; 
an update on the Workshop on Implementing Immunization 
Recommendations; discussion on the impact of vaccine shortages on 
coverage and the assessment of coverage; an update on the IOM Study 
on Financing Vaccines; and a discussion of pertinent areas for Unmet 
Needs funding.

    Name: Subcommittee on Vaccine Safety and Communication.
    Time and Date: 2 p.m.-5 p.m., June 4, 2002.
    Place: Hubert H. Humphrey Building, Room 325A, 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: This subcommittee reviews issues relevant to vaccine 
safety and adverse reactions to vaccines.
    Matters to be Discussed: A report on the Clinical Immunization 
Safety Assessment Centers; a report and discussion of the IOM 
Vaccine Safety Committee Report on Hepatitis B Vaccine and 
Neurological Disorders; and a discussion of future focus areas for 
the IOM Vaccine Safety Committee.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Gloria Sagar, Committee 
Management Specialist, NVPO, CDC, 4700 Buford Highway M/S K-77, 
Chamblee, Georgia 30341, telephone 770/488-2040.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: May 9, 2002.
Alvin Hall,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 02-12236 Filed 5-15-02; 8:45 am]
BILLING CODE 4163-18-P